To assess the efficacy of Selective Laser Trabeculoplasty (SLT) as primary treatment for open-angle glaucoma in treatment-naïve black patients in south east Nigeria.
Approach:
Key Findings:
SLT resulted in significant IOP reduction in treatment-naïve patients (p < 0.05).
Success defined as IOP reduction of ≥ 3 mmHg or ≥ 20% from baseline.
Efficacy of SLT aligns with findings from previous studies in other populations.
Interpretation:
SLT is an effective initial treatment for open-angle glaucoma in the studied population, showing promising IOP reduction and medication savings, which could influence clinical practice in Nigeria.
Limitations:
Retrospective design may introduce bias, potentially affecting the reliability of the results.
Lack of standardized IOP measurements across patients.
Conclusion:
SLT is a viable first-line treatment for glaucoma in south eastern Nigeria, though barriers to implementation, such as cost and training, remain.